Se IASLC/UICC Mesothelioma Staging Manual, 8th edition, 2016 (Rusch et al., 2016).
Stadium | Forklaring |
|---|---|
T1 | Tumor limited to the ipsilateral parietal ± visceral ± mediastinal ± diaphragmatic pleura |
T2 | Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: •involvement of diaphragmatic muscle •extension of tumor from visceral pleura into the underlying pulmonary parenchyma |
T3 | Describes locally advanced but potentially resectable tumor. Tumor involving all of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features:
|
T4 | Describes locally advanced technically unresectable tumor. Tumor involving all of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features:
|
N1 | Metastases in the ipsilateral bronchopulmonary, hilar, or mediastinal (including the internal mammary, peridiaphragmatic, pericardial fat pad, or intercostal lymph nodes) lymph nodes |
N2 | Metastases in the contralateral mediastinal, ipsilateral, or contralateral supraclavicular lymph nodes |
M1 | Distant metastasis present |
Gjengitt fra Brierley et al., 2017. Med tillatelse fra John Wiley and Sons i 2024.
Stadium | N0 | N1 | N2 |
|---|---|---|---|
T1 | IA | II | IIIB |
T2 | IB | II | IIIB |
T3 | IB | IIIA | IIIB |
T4 | IIIB | IIIB | IIIB |
M1 | IV | IV | IV |
Gjengitt fra Brierley et al., 2017. Med tillatelse fra John Wiley and Sons i 2024.